ask="1.000"
ask_size="3000"
average_daily_volume="130982"
bid="0.770"
bid_size="3000"
book_value="0.684"
change="-0.011"
change_from_200_day_moving_average="-0.041"
change_from_50_day_moving_average="-0.035"
change_from_52_week_high="-0.503"
change_From_52_week_low="0.207"
change_in_percent="-1.185%"
close="0.917"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.273"
ebitda="-15.76M"
eps_estimate_current_year="-0.290"
eps_estimate_next_quarter="-0.010"
eps_estimate_next_year="-0.110"
ex_dividend_date="N/A"
float_shares="43214000"
high="0.917"
high_52_weeks="1.420"
last_trade_date="1/23/2017"
last_trade_price="0.917"
last_trade_size="2500"
last_trade_time="3:59pm"
low="0.881"
low_52_weeks="0.710"
market_capitalization="51.75M"
moving_average_200_day="0.958"
moving_average_50_day="0.952"
name="BioLineRx Ltd."
notes="N/A"
one_year_target_price="2.000"
open="0.891"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-4.286%"
percent_change_from_50_day_moving_average="-3.658%"
percent_change_from_52_week_high="-35.423%"
percent_change_from_52_week_low="+29.155%"
previous_close="0.928"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.357"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="56432000"
short_ratio="0.390"
stock_exchange="NCM"
symbol="BLRX"
volume="65901"
weeks_range_52="0.710 - 1.420"
